ClinicalTrials.Veeva

Menu

Ocular Mysathenia Gravis Generalization (MYASTEN)

F

Fondation Ophtalmologique Adolphe de Rothschild

Status

Completed

Conditions

Ocular Myasthenia Gravis

Treatments

Other: Use of nomogram for predictions of Ocular Mysathenia Gravis generalization

Study type

Observational

Funder types

NETWORK

Identifiers

NCT04667650
CE_20161027_22_AGN

Details and patient eligibility

About

Secondary ocular myasthenia gravis (OMG) generalization represents a pejorative evolution and no validated generalization prevention strategy exists. The aim of this observational study was to determine the percentage of patients with OMG generalization and identify factors predictive of that pejorative evolution. Data from patients with OMG registered in the Fondation Hospital A. de Rothschild database between January 1990 and January 2017 were collected. Among the 183 patients registered in this database, 151 patients with available informations were analyzed.

Enrollment

151 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with OMG diagnosis and its generalization who consulted between January 1990 to January 2017 at Fondation Hospital Adolphe de Rothschild and registered in the database

Exclusion criteria

  • OMG differential diagnoses

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems